# FDA Approves Generic Dapagliflozin from Alembic Pharmaceuticals The U.S. FDA has approved Alembic Pharmaceuticals Limited's generic dapagliflozin o...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
Sun Pharmaceutical Industries, Inc. secured FDA approval for its oral generic Dapagliflozin and Metformin Hydrochloride tablets, positioning the compa...
Cipla USA Inc. secured FDA approval for its generic oral tablet of Dapagliflozin, positioning the manufacturer to capture market share in the growing ...
Biocon Pharma Inc. secured FDA approval for its generic oral formulation of Dapagliflozin via ANDA211470, with the product slated for a market entry i...
Ascend Laboratories received FDA approval for its Generic Dapagliflozin and Metformin Hydrochloride tablets, a critical oral combination therapy for t...
The FDA has granted full approval to generic dapagliflozin manufactured by Apotex Corp., paving the way for the company to capture market share in the...
Aurobindo Pharma Limited announced the approval of its ANDA for dapagliflozin, granting it rights to manufacture and market this generic oral product ...
# FDA Approves Baxter Healthcare's Generic Phenylephrine Hydrochloride Injection Baxter Healthcare Corporation has received FDA approval for its gene...
# FDA Approves Sandoz's Generic Nintedanib, Expanding Competition in Pulmonary Fibrosis Market Sandoz Inc. has received FDA approval for its generic ...
# FDA Approves Dr. Reddy's Laboratories' Generic Nintedanib Dr. Reddy's Laboratories Inc. received FDA approval for its generic nintedanib esylate or...
# FDA Approves Generic Version of Nintedanib, Enabling Significant Cost Savings for Pulmonary Fibrosis Patients Apotex Corp. has received FDA approva...
# FDA Approves Generic Nintedanib Capsules; Exelan Pharmaceuticals Enters Competitive Pulmonary Fibrosis Market Exelan Pharmaceuticals Inc. has recei...
Edenbridge Pharmaceuticals LLC has received FDA approval for its ANDA219819 application for Nintedanib Esyslate tablets, strengthening the firm’s port...
# FDA Approves Eli Lilly's FOUNDAYO for Oral Administration Eli Lilly and Company received FDA approval for FOUNDAYO (orforglipron calcium), an oral ...
# FDA Approves KLM Laboratories' Generic Mesalamine Rectal Formulation KLM Laboratories Private Limited received FDA approval for its generic mesalam...
# FDA Approves Generic Olmesartan Medoxomil and Hydrochlorothiazide Combination ScieGen Pharmaceuticals Inc received FDA approval for a generic versi...
# FDA Approves Baxter Healthcare's Intramuscular Epinephrine Formulation Baxter Healthcare Corporation received FDA approval for its intramuscular ep...
On March 27, 2026, Teva Pharmaceutical Industries received FDA approval for unspecified new agents contained in BLA761385, a milestone that signals th...
On March 26, 2026, SAGENT received FDA approval for a new drug, signaling a strategic entry into the market with potential to compete against existing...
# FDA Approves Denali Therapeutics' AVLAYAH, Expanding Its Neurology Portfolio Denali Therapeutics Inc. received FDA approval for AVLAYAH (tividenofu...